definiens: shall mean the opt imal effectiveness, productivity or success of the Collaboration, including with respec t to ( a ) the execution of any Pre - project, Project, Targ et Discovery Plan or Drug Discovery Plan ( including any project undertaken pursuant to such plans ) ; ( b ) the identification, discovery, development or c ommercialization of any Collaboration Targets, Drug Candidates, Licensed Pr oducts, Niche Candidates or Residual Products ( including, in each case, with re spect to any assessment, testing, manufacturing, pre - clinical or clinical de velopment or use, or FDA, EMEA or other regulatory authority application, sub mission, authorization or approval with respect thereto ; ( c ) the generation or acquisition of IPR by or on behal f of either or both of the Parties or any of their respective Affiliates ( including an y rights in respect of any Know - How, Research Technology or Patents ) with respect t o any of the foregoing, or the prosecution, maintenance or enforcement of any such rights of either or both Parties or any of t heir respective Affiliates with respect thereto ; or ( d ) the exercise of any rights or licenses, perform ance of any obligations, or conducting of any other activities authorized or re quired by this Agreement